PHOENIX-OITB’s mission is to offer a Single-Entry-Point for a consolidated network of facilities, technologies, services and expertise for all the technology transfer aspects:
From characterization, testing, verification up to scale-up, GMP compliant manufacturing and regulatory guidance in the field of nanopharmaceutical development, framing the OITB clearly within the nanomedicine field.
All interested research groups can apply to this call.
The services and expertise provided by the PHOENIX-OITB include production and characterisation under GMP conditions, safety evaluation, regulatory compliance and commercialisation boost. The Open Call will offer funded services in the following categories:
Any legal entity (SMEs, start up or RTOs) and research group, based in the European Union or associate countries of H2020 can apply to this call.
The Evaluation Committee will evaluate each proposal in three main criteria:
The applicants will be informed about the decision made by the Evaluation Committee by the end of 03.04.2023 via email. A Stage 2 detailed application must then be submitted by 30.04.2023. Awarded projects must be completed by February 2025.
More information in the project Open Call website.
More information about the PHOENIX-OITB project and ICMAB participation.